Does Testosterone Replacement Therapy Affect Penis Size?

Testosterone replacement therapy (TRT) does not increase penis size in adults who have already been through puberty. The research is consistent on this point: studies measuring penile length in men receiving TRT find no significant gains, and recent clinical guidelines explicitly recommend against using hormonal therapy for penile augmentation after puberty. The story is more complicated in children with micropenis and in people experiencing severe testosterone deprivation, but for a typical adult man on TRT, the expectation of added length is not supported by the evidence.

Why the Answer Depends on Age

Testosterone drives penile growth during two critical windows: fetal development and puberty. In the womb, a related hormone called dihydrotestosterone (DHT) is responsible for forming external genitalia, while testosterone itself handles internal structures and later triggers the changes of puberty.¹ Once puberty is complete and growth plates have closed, the penis has essentially reached its final size. Adding more testosterone after that point does not restart the growth process.

Research on fetal penile tissue helps explain why. Testosterone drives penile growth partly through expansion of the tissue surrounding smooth muscle cells, but the growth eventually stops through mechanisms that are not simply about running out of hormone. Studies on androgen receptors in penile tissue found that the number of receptor-positive cells stayed the same regardless of whether testosterone was low, normal, or elevated, suggesting the tissue’s responsiveness has a built-in ceiling.² In other words, flooding the tissue with more hormone does not create more docking sites for it.

The Saturation Point in Adult Penile Tissue

One reason TRT does not enlarge the adult penis is that the erectile tissue appears to reach a saturation point at relatively modest testosterone levels. Research on androgen receptor signaling in human erectile tissue found that once serum testosterone exceeds roughly 200 ng/dL, there is no further increase in receptor activity or in VEGF expression, a marker of blood vessel maintenance.³ A separate study evaluating androgen receptor markers in men with erectile dysfunction arrived at a similar figure, finding that receptor signaling dropped off only below about 200 to 300 ng/dL.⁴

Most men beginning TRT have testosterone levels that are low but still above this threshold, or their levels are being brought into a range where the tissue is already maximally responsive. That is why pushing testosterone higher with replacement therapy does not translate to structural changes in the penis. The tissue has already gotten the signal it needs; a louder signal does not make it respond differently.

This also aligns with population-level data. A study examining the relationship between testosterone and stretched penile length in adult men found only a weak statistical association, and the researchers specifically cautioned that the finding “does not mean that men with higher testosterone levels have larger penises and by no means suggests that exogenous testosterone or testosterone replacement therapy will increase penile length.”⁵ Another study tracking men on long-term testosterone therapy with objective measurements found no significant changes in penile length.⁶

Genetic Variation and Androgen Sensitivity

Some men wonder whether individual differences in androgen receptor sensitivity could make them more or less responsive to testosterone in terms of penile size. The androgen receptor gene has a repeating segment (a CAG repeat) that varies in length between individuals, and longer repeats are associated with weaker receptor activity. A cross-sectional study in adult men investigated whether this genetic variation or testosterone levels predicted penile length. Neither did. Testosterone levels correlated with the length of the CAG repeat, but neither testosterone nor the repeat length correlated with penile size.⁷ The researchers did find an unexpected link between prolactin levels and penile length, but the overall message was clear: in fully developed adults, circulating testosterone is not a meaningful predictor of size.

When Testosterone Therapy Does Change Penile Size

The situation is genuinely different in children with micropenis, a condition where the penis is more than 2.5 standard deviations below the mean for age. In these patients, testosterone therapy produces substantial and clinically meaningful growth. A study of children under 11 found that hormonal treatment increased mean penile length from about 15.5 mm to 37.2 mm, and in children over 11, from about 26.4 mm to 64.3 mm.⁸ These are children whose tissue still has active growth potential, and the testosterone is providing a signal the body was unable to produce on its own.

Long-term outcomes are encouraging, too. In a study of boys with micropenis caused by fetal testosterone deficiency, those treated with short courses of testosterone injections during infancy or childhood reached an average adult penile length of about 10.3 cm, within two standard deviations of the general adult mean of roughly 12.4 cm.⁹ Treatment did not give them above-average size, but it brought them into the normal range, and there was no evidence that early androgen exposure led to a shorter final adult length.

Some cases involve conditions like partial androgen insensitivity syndrome, where the body’s receptors respond poorly to testosterone. Even in these patients, testosterone injections during infancy have been reported to normalize penile length in several cases, though the response varies widely depending on the specific genetic mutation involved.¹⁰

Topical Versus Injected Testosterone in Children

For pediatric micropenis, clinicians have explored both injected testosterone and topical DHT cream applied directly to the penis. A comparative study of the two approaches in infants and young boys found that topical DHT produced a slightly larger gain in penile length, with a mean increase of about 2.4 cm compared with about 1.8 cm for injected testosterone.¹¹ Both methods brought the treated children into a near-normal range for their age.

A separate study comparing topical testosterone with intramuscular injections in boys with microphallic hypospadias found that both routes produced growth of at least 50 percent in most patients, with no statistically significant difference between the two approaches.¹² Topical application has the theoretical advantage of delivering hormone directly to the target tissue, and DHT in particular does not need to be converted further before acting on androgen receptors. But the practical difference between methods is modest, and both are used in clinical practice depending on the situation.

None of this translates to adults. Applying testosterone cream to the penis of a fully grown man does not produce the same growth response because the developmental window has closed. The clinical literature on topical androgens for penile augmentation is entirely in prepubertal populations.

What Happens When Testosterone Drops to Near Zero

If testosterone does not increase adult penile size, what happens when testosterone is removed altogether? This question has an answer from prostate cancer treatment. Men placed on androgen deprivation therapy (ADT), which suppresses testosterone to castrate levels, experience measurable penile shrinkage. One prospective study found that mean stretched penile length decreased from about 10.8 cm to about 8.1 cm over 24 months of ADT, with the changes plateauing after roughly 15 months.¹³

The mechanism behind this shrinkage involves changes at the tissue level. Animal studies show that castration causes the smooth muscle inside the erectile bodies to lose bulk and shift toward a more fibrous, collagen-heavy composition. In castrated rats, the smooth-muscle-to-collagen ratio drops significantly, and the expression of key smooth muscle proteins decreases.¹⁴ Similar findings appear in other rat studies showing greater fibrosis and increased cell death in the erectile tissue after castration.¹⁵ Testosterone replacement in these animals prevents or partially reverses these tissue changes, maintaining the smooth muscle content and penile diameter at normal levels.¹⁶

This creates an important distinction. TRT cannot make a normal penis bigger, but it may prevent or partially reverse tissue-level deterioration when testosterone has been at near-zero levels. For men recovering from ADT or those with profoundly low testosterone due to pituitary failure or bilateral orchiectomy, restoring testosterone to a normal range could preserve or recover some of the smooth muscle integrity that supports penile structure. That is not the same as enlargement; it is maintenance and repair of tissue that was actively degrading.

Transmasculine Hormone Therapy

One population where exogenous testosterone does produce measurable genital growth is transmasculine individuals (those assigned female at birth who take testosterone as part of gender-affirming care). In this context, the clitoris, which is embryologically equivalent to the penis, can grow by up to about 2 cm with testosterone therapy.¹⁷ This is because the clitoral tissue has never been exposed to high androgen levels before, so it is encountering the growth-promoting effects of testosterone for the first time. It is functionally more similar to the pediatric micropenis scenario than to TRT in a cisgender adult man whose penile tissue already had a full puberty’s worth of androgen exposure.

What Clinical Guidelines Say

Professional medical organizations have taken a clear position. The 2024 recommendations from the Fifth International Consultation on Sexual Medicine state that hormonal therapy for penile augmentation should only be offered to prepubertal patients with micropenis or disorders of sex development, and explicitly advise against using testosterone or other hormones to increase penile size after puberty.¹⁸ This is not a soft suggestion; the guideline uses the word “do not.”

The reasoning behind this recommendation lines up with everything the research shows. In prepubertal tissue that has not yet reached its growth potential, androgens can complete the job that the body’s own hormones were unable to. In post-pubertal tissue, the growth machinery has already run its course and the androgen receptors in the erectile bodies are already saturated at normal testosterone levels. Prescribing TRT with the expectation of penile enlargement in an adult man would be off-label use without supporting evidence, and carries the real risks that come with supraphysiologic or unnecessary hormone dosing, including cardiovascular and prostate concerns.

Dihydrotestosterone Deficiency and an Unusual Exception

There is a narrow physiological scenario where androgens can influence penile size later than usual. People born with 5-alpha reductase type 2 deficiency cannot efficiently convert testosterone into DHT, the more potent androgen that drives external genital formation in utero and during puberty. This enzyme deficiency results in a spectrum of undervirilized genitalia, sometimes including micropenis.¹⁹ In these individuals, the penile tissue may not have been fully exposed to the androgenic signals it needed during development, creating a window for response to DHT treatment even at or after puberty. This is a rare congenital condition and not analogous to the typical adult man seeking TRT.

Why Men on TRT Sometimes Perceive a Change

Despite the evidence, many men on TRT anecdotally report that their penis “looks bigger” or “feels different.” Several factors may explain this without any actual change in length. TRT commonly improves erectile function, and a firmer, more reliable erection can create the perception of increased size even though the underlying tissue has not grown. Improved blood flow, better mood, and reduced body fat around the pubic area can all contribute to a visual or tactile difference. Weight loss alone can reveal more of the penile shaft that was previously buried under a fat pad, which is sometimes called “hidden penis” and is unrelated to hormonal therapy per se.

There is also a psychological dimension. Men who start TRT often feel more confident, more energetic, and more sexually engaged. These psychological shifts can change how someone perceives their own body, including genital size. The difference between a solid erection in someone who feels good and a half-hearted one in someone who feels lousy can be genuinely striking, even when measured dimensions have not moved.

Supplements and Over-the-Counter “Testosterone Boosters”

A thriving market of supplements claims to boost testosterone and, by extension, to enhance penile size. These products typically contain zinc, fenugreek, D-aspartic acid, tribulus terrestris, or similar ingredients. Even setting aside the question of whether these actually raise testosterone meaningfully, the underlying premise fails: as described above, raising testosterone in an adult with already-normal levels does not increase penile size. A supplement that hypothetically brought testosterone from 400 ng/dL to 500 ng/dL would still be operating well above the saturation threshold where penile tissue has already maximized its androgen signaling. The entire category of products promising penile growth through testosterone enhancement is built on a misunderstanding of how the tissue responds to hormones after puberty.

Men with genuinely low testosterone who are experiencing erectile dysfunction, low libido, or fatigue should discuss TRT with a physician, because the therapy can meaningfully improve quality of life and sexual function. But the benefit is in function, not in structural size, and purchasing unregulated supplements for a goal that prescription-grade testosterone itself cannot achieve is spending money on a biological impossibility.